Does mRNA SARS‐CoV‐2 vaccine in the follicular fluid impact follicle and oocyte performance in IVF treatments?

PROBLEM: The COVID‐19 pandemic has many clinical manifestations. Rapid vaccine development raised concerns and speculations about future fertility outcomes and vaccine safety. We evaluated the effect of Pfizer‐BioNTech mRNA SARS‐CoV‐2 vaccine on IVF treatment, oocyte and embryo quality, and pregnanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Odeh‐Natour, Rasha, Shapira, Maanit, Estrada, Daniela, Freimann, Sarit, Tal, Yana, Atzmon, Yuval, Bilgory, Asaf, Aslih, Nardin, Abu‐Raya, Yasmin Shibli, Shalom‐Paz, Einat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Immunologiocal Factors in Reproduction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111235/
https://www.ncbi.nlm.nih.gov/pubmed/35220640
http://dx.doi.org/10.1111/aji.13530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111235/
https://www.ncbi.nlm.nih.gov/pubmed/35220640
http://dx.doi.org/10.1111/aji.13530

Ejemplares similares